Nexgenrx Inc (NXG.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 4,616 | 4,346 | 4,551 | 3,939 | 4,159 |
| Cost of Goods | 766 | 785 | 927 | 567 | 992 |
| Gross Profit | 3,850 | 3,561 | 3,624 | 3,372 | 3,166 |
| Operating Expenses | 3,241 | 3,222 | 3,074 | 2,906 | 2,998 |
| Operating Income | 609 | 339 | 550 | 465 | 168 |
| Interest Expense | 7 | 8 | 8 | -25 | 8 |
| Other Income | -36 | -1 | -38 | -38 | -34 |
| Pre-tax Income | 567 | 331 | 504 | 453 | 126 |
| Income Tax | -23 | -23 | -23 | 481 | -23 |
| Net Income Continuous | 590 | 354 | 527 | -28 | 149 |
| Net Income | $590 | $354 | $527 | $-28 | $149 |
| EPS Basic Total Ops | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| EBITDA(a) | $887 | $661 | $826 | $744 | $444 |